Additionally, there is no set compensation in product liability claims against a pharmaceutical company like Novo Nordisk
Patients were randomized 1:1 to receive subcutaneous semaglutide 2.4 mg once weekly or placebo as an adjunct to standard-of-care therapy for CVD, such as cholesterol-modifying medications, antiplatelet therapies and antihypertensive agents
Researchers, including Steinert et al
This article is for general educational purposes and is not individualized medical advice
We invest as many resources and as much time as necessary, working around the clock to ensure that each client receives fair compensation for their harms and losses
Noom Weight Behavior change program with psychology-based lessons, habit tracking, and optional coaching to help you lose weight and build lasting habits